CHEMOCENTRYX INC's ticker is CCXI and the CUSIP is 16383L106. A total of 165 filers reported holding CHEMOCENTRYX INC in Q1 2020. The put-call ratio across all filers is 0.52 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $14,000 | +100.0% | 265 | 0.0% | 0.00% | – |
| Q2 2022 | $7,000 | +40.0% | 265 | +29.9% | 0.00% | – |
| Q1 2022 | $5,000 | -28.6% | 204 | 0.0% | 0.00% | – |
| Q4 2021 | $7,000 | +75.0% | 204 | -14.6% | 0.00% | – |
| Q3 2021 | $4,000 | +100.0% | 239 | +74.5% | 0.00% | – |
| Q2 2021 | $2,000 | -71.4% | 137 | 0.0% | 0.00% | – |
| Q1 2021 | $7,000 | -12.5% | 137 | +5.4% | 0.00% | – |
| Q4 2020 | $8,000 | -61.9% | 130 | -66.6% | 0.00% | – |
| Q3 2020 | $21,000 | +61.5% | 389 | +18.2% | 0.00% | – |
| Q2 2020 | $13,000 | 0.0% | 329 | 0.0% | 0.00% | – |
| Q1 2020 | $13,000 | 0.0% | 329 | 0.0% | 0.00% | – |
| Q4 2019 | $13,000 | +550.0% | 329 | -9.9% | 0.00% | – |
| Q3 2019 | $2,000 | -33.3% | 365 | 0.0% | 0.00% | – |
| Q2 2019 | $3,000 | -25.0% | 365 | +35.7% | 0.00% | – |
| Q1 2019 | $4,000 | +33.3% | 269 | 0.0% | 0.00% | – |
| Q4 2018 | $3,000 | 0.0% | 269 | 0.0% | 0.00% | – |
| Q3 2018 | $3,000 | -25.0% | 269 | 0.0% | 0.00% | – |
| Q2 2018 | $4,000 | 0.0% | 269 | 0.0% | 0.00% | – |
| Q1 2018 | $4,000 | – | 269 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 276,400 | $4,726,000 | 1.88% |
| TANG CAPITAL MANAGEMENT LLC | 500,000 | $8,550,000 | 1.78% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 94,300 | $7,131,000 | 1.72% |
| Integral Health Asset Management, LLC | 300,000 | $5,130,000 | 1.48% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 139,200 | $2,380,000 | 1.35% |
| MANGROVE PARTNERS IM, LLC | 686,300 | $11,736,000 | 1.05% |
| Ikarian Capital, LLC | 600,000 | $10,261,000 | 0.72% |
| Ikarian Capital, LLC | 600,000 | $10,260,000 | 0.72% |
| Sofinnova Investments, Inc. | 517,708 | $8,853,000 | 0.52% |
| Birchview Capital, LP | 25,000 | $428,000 | 0.29% |